TrademarkDir
GP CR THERAPEUTICS
DEAD

Serial Number

97501179

Owner

GPCR Therapeutics, Inc.

Attorney

Tyler E. Baker

Filing Date

Jul 13, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GP CR THERAPEUTICS Trademark

Serial Number: 97501179

GP CR THERAPEUTICS is a trademark filed by GPCR Therapeutics, Inc. on July 13, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

GPCR Therapeutics, Inc. (2 trademarks)

Room 407, Nakseongdae R&D Center
Seoul 08790 , KR

Entity Type: 03

Trademark Details

Filing Date

July 13, 2022

Registration Date

Not Registered

Published for Opposition

June 6, 2023

Goods & Services

Medical diagnostic apparatus for detecting cancer, and mobilization/collection of cells, including stem cells and immune cells

Pharmaceutical products for the treatment of cancer, and mobilization/collection of cells, including stem cells and immune cells; biological preparations for the treatment of cancer, and mobilization/collection of cells, including stem cells and immune cells

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 9, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 9, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 2, 2025 EXRA
SOU EXTENSION 4 GRANTED
Aug 1, 2025 EX4G
SOU EXTENSION 4 FILED
Aug 1, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 1, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jan 31, 2025 EX3G
SOU EXTENSION 3 FILED
Jan 31, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 31, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 1, 2024 EXRA
SOU EXTENSION 2 GRANTED
Aug 1, 2024 EX2G
SOU EXTENSION 2 FILED
Aug 1, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 1, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 28, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 28, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 28, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 17, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 17, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 17, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 1, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 2, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
May 2, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 2, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
May 2, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 2, 2023 CNEA
ASSIGNED TO EXAMINER
Apr 27, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 3, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 2, 2022 NWOS
NEW APPLICATION ENTERED
Jul 16, 2022 NWAP

Related Trademarks

More from this Owner

GPCR THERAPEUTICS logo

GPCR THERAPEUTICS

GPCR THERAPEUTICS logo

GPCR THERAPEUTICS